AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-3092694_ITM" title="Facts and information about Abraxane approved.(PRODUCTS)">Abraxane approved.(PRODUCTS)</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Abraxane approved.(PRODUCTS)
Abraxane for injectable suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) has been approved for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec.
- News wire article from: The America's Intelligence Wire June 29, 2009 700+ words
...listing of ABRAXANE(R) for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) 100...Administration approved ABRAXANE for Injectable Suspension (paclitaxel protein-bound...
- Abraxane approved for advanced breast cancer patient treatment in Quebec.
- News wire article from: Chemical Business Newsbase June 29, 2009 700+ words
Abraxis BioScience Inc (Abraxis) announced the listing of Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) 100 mg in Quebec for the treatment of metastatic breast...
- Abraxane approved.(products)(Brief Article)(Advertisement)
- Magazine article from: Family Practice News July 1, 2005 700+ words
Abraxane for injectable suspension (paclitaxel protein-bound particles for injectable suspension, albumin-bound) has been approved for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse...
- Abraxane approved for advanced breast cancer treatment in Canada.
- News wire article from: Chemical Business Newsbase September 13, 2006 700+ words
(From Chemical Business NewsBase - Press Release) Abraxis Oncology has received Health Canada approval for Abraxane for the treatment of metastatic breast cancer, including previously untreated metastatic disease. Abraxane, a unique new cancer therapy, is now commercially available. It uses the
- Teva Announces Approval of Methylprednisolone Acetate Injectable Suspension.
- Press release article from: Business Wire February 24, 2005 700+ words
...for the Company's ANDA for Methylprednisolone Acetate Injectable Suspension, 40 mg/mL and 80 mg/mL in single dose vials. Teva's Methylprednisolone Acetate Injectable Suspension is the AP-rated generic equivalent of Pfizer's Depo...
- Teva Announces Approval of Medroxyprogesterone Acetate Injectable Suspension.
- Press release article from: Business Wire July 29, 2004 700+ words
...the Company's ANDA for Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL in single-dose vials. This is the...approval for this product. Medroxyprogesterone Acetate Injectable Suspension is the generic equivalent of Pfizer's Depo-Provera...
- Watson Pharmaceuticals' TRELSTAR(R) DEPOT and TRELSTAR(R) LA (Triptorelin...
- Press release article from: PR Newswire April 4, 2005 700+ words
...DEPOT and TRELSTAR(R) LA (triptorelin pamoate for injectable suspension) for the palliative treatment of advanced prostate cancer...DEPOT and TRELSTAR(R) LA (triptorelin pamoate for injectable suspension) are one- and three-month sustained-release formulations...
- Approval: naltrexone injectable suspension (Vivitrol).(From the FDA)(Brief...
- Magazine article from: Brown University Psychopharmacology Update June 1, 2006 700+ words
On April 14 the FDA approved naltrexone injectable suspension for extended release (Vivitrol) the first injectable medication for treating alcohol dependence. Vivitrol is an opioid antagonist...
- Approval: Naltrexone injectable suspension (Vivitrol).(From the FDA)(Brief...
- Newspaper article from: The Brown University Geriatric Psychopharmacology Update June 1, 2006 700+ words
On April 14 the FDA approved naltrexone injectable suspension for extended release (Vivitrol) the first injectable medication for treating alcohol dependence. Vivitrol is an opioid antagonist...
- Pharmion launches Vidaza (azacitidine for injectable suspension).
- News wire article from: Asia Africa Intelligence Wire July 6, 2004 700+ words
...Business NewsBase - Press Release) Pharmion Corp commenced its US commercial launch of Vidaza (azacitidine for injectable suspension) on 1 Jul 2004 with the shipment of initial supplies of the recently-approved drug. Pharmion received full...
Source: HighBeam Research, Abraxane approved.(PRODUCTS)